EA202190046A1 - N-замещенные производные тетрагидротиенопиридина и их применение - Google Patents

N-замещенные производные тетрагидротиенопиридина и их применение

Info

Publication number
EA202190046A1
EA202190046A1 EA202190046A EA202190046A EA202190046A1 EA 202190046 A1 EA202190046 A1 EA 202190046A1 EA 202190046 A EA202190046 A EA 202190046A EA 202190046 A EA202190046 A EA 202190046A EA 202190046 A1 EA202190046 A1 EA 202190046A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
substituted
tetrahydrothienopyridine derivatives
derivatives
substituted tetrahydrothienopyridine
Prior art date
Application number
EA202190046A
Other languages
English (en)
Inventor
Сириль Кунде
Вэй Линь Сандра Симь
Оливер Саймон
Ган Ван
Хой Цюань Ео
Брайан Кс Йеунг
Фумиаки Йококава
Бинь Цзоу
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA202190046A1 publication Critical patent/EA202190046A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Предложено соединение формулы (I), которое, как было показано, полезно для лечения заболевания, вызванного вирусной инфекциейгде R1, R2, R3, A, L, m, n, p и q такие, как определено в изобретении.
EA202190046A 2018-06-19 2019-06-18 N-замещенные производные тетрагидротиенопиридина и их применение EA202190046A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862687068P 2018-06-19 2018-06-19
PCT/IB2019/055121 WO2019244047A1 (en) 2018-06-19 2019-06-18 N-substituted tetrahydrothienopyridine derivatives and uses thereof

Publications (1)

Publication Number Publication Date
EA202190046A1 true EA202190046A1 (ru) 2021-03-24

Family

ID=67841114

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190046A EA202190046A1 (ru) 2018-06-19 2019-06-18 N-замещенные производные тетрагидротиенопиридина и их применение

Country Status (23)

Country Link
US (1) US20220073535A1 (ru)
EP (2) EP4169925A3 (ru)
JP (1) JP7328260B2 (ru)
KR (1) KR20210022645A (ru)
CN (1) CN112313237A (ru)
AU (1) AU2019291488B2 (ru)
BR (1) BR112020025696A2 (ru)
CA (1) CA3100957A1 (ru)
CL (1) CL2020003248A1 (ru)
CR (1) CR20200618A (ru)
CU (1) CU20200100A7 (ru)
EA (1) EA202190046A1 (ru)
EC (1) ECSP20080995A (ru)
ES (1) ES2941946T3 (ru)
IL (1) IL279441B2 (ru)
JO (1) JOP20200326A1 (ru)
MA (1) MA52976A (ru)
MX (1) MX2020013852A (ru)
PE (1) PE20210097A1 (ru)
PH (1) PH12020552185A1 (ru)
SA (1) SA520420809B1 (ru)
SG (1) SG11202012625PA (ru)
WO (1) WO2019244047A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019024809A1 (zh) * 2017-08-01 2019-02-07 正大天晴药业集团股份有限公司 作为RORγ抑制剂的双环化合物
USD1006154S1 (en) * 2023-06-27 2023-11-28 Qiongfang Mao Cable crossover attachment

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US498178A (en) 1893-05-23 William valentine leonard
US54472A (en) 1866-05-01 Improved blacking-brush
US6344A (en) 1849-04-17 Driving-bobbin
US8766A (en) 1852-02-24 Appabatus for lightening vessels
US4656A (en) 1846-07-24 Improvement in potato-plows
US5807A (en) 1848-09-26 Brake fob cabs
US5807876A (en) 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
AU723730B2 (en) 1996-04-23 2000-09-07 Vertex Pharmaceuticals Incorporated Urea derivatives as inhibitors of IMPDH enzyme
ATE244717T1 (de) 1997-03-14 2003-07-15 Vertex Pharma Inhibitoren des impdh-enzyms
AR029341A1 (es) 1999-03-19 2003-06-25 Vertex Pharma Inhibidores de la enzima impdh (inosina-5'-monofosfato dehidrogenasa)
US7138529B2 (en) * 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
AP3069A (en) 2009-02-27 2014-12-31 Siga Technologies Inc Thienopyridine derivatives for the treatment and prvention of dengue virus infection
US20130129677A1 (en) * 2009-02-27 2013-05-23 Siga Technologies, Inc. Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
JP5701655B2 (ja) 2011-03-29 2015-04-15 奈良県 植物精油中のトロポロン類及び／又はフェノール類の金属錯体化方法
CN108689987A (zh) * 2017-04-05 2018-10-23 浙江海正药业股份有限公司 一种磺胺类衍生物及其制备方法和用途
CR20190531A (es) * 2017-05-22 2020-03-05 Janssen Pharmaceuticals Inc Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
CN108191885B (zh) * 2018-01-29 2020-08-04 华东师范大学 一类哌啶并噻吩类小分子有机化合物及其应用

Also Published As

Publication number Publication date
US20220073535A1 (en) 2022-03-10
PH12020552185A1 (en) 2021-06-07
EP4169925A3 (en) 2023-06-14
JP7328260B2 (ja) 2023-08-16
CR20200618A (es) 2021-01-21
JOP20200326A1 (ar) 2020-12-14
SG11202012625PA (en) 2021-01-28
CN112313237A (zh) 2021-02-02
PE20210097A1 (es) 2021-01-12
IL279441A (en) 2021-01-31
SA520420809B1 (ar) 2022-08-17
AU2019291488A1 (en) 2021-02-04
CL2020003248A1 (es) 2021-07-09
WO2019244047A1 (en) 2019-12-26
IL279441B2 (en) 2023-06-01
EP4169925A2 (en) 2023-04-26
BR112020025696A2 (pt) 2021-03-16
CU20200100A7 (es) 2021-08-06
KR20210022645A (ko) 2021-03-03
EP3810613A1 (en) 2021-04-28
ES2941946T3 (es) 2023-05-26
EP3810613B1 (en) 2023-01-11
MA52976A (fr) 2021-04-28
AU2019291488B2 (en) 2022-02-24
CA3100957A1 (en) 2019-12-26
ECSP20080995A (es) 2021-02-26
JP2021529159A (ja) 2021-10-28
MX2020013852A (es) 2021-05-27

Similar Documents

Publication Publication Date Title
EA201992884A2 (ru) Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний
EA201592126A1 (ru) 6-мостиковые гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
MX2022005839A (es) Compuestos utiles como inhibidores de la proteina helios.
PE20171341A1 (es) Compuestos de pirazina para el tratamiento de enfermedades infecciosas
EA201591457A1 (ru) Терапевтические соединения
EA201691261A1 (ru) Новые дигидрохинолизиноны для лечения и профилактики инфекции, вызванной вирусом гепатита b
MX2022005160A (es) Oxisteroles y metodos de uso de los mismos.
NZ631726A (en) Therapeutic compounds for the treatment of viral infections
EA201590384A1 (ru) 6-аминокислота-гетероарилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в
EA201690978A1 (ru) ПИРРОЛО[1.2-f][1.2.4]ТРИАЗИНЫ, ИСПОЛЬЗУЕМЫЕ ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫХ ВИРУСНЫХ ИНФЕКЦИЙ
EA201690153A1 (ru) Замещенные бензофуранильные и бензоксазолильные соединения и их применения
EA201991349A1 (ru) Тетрациклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич
EA202092263A1 (ru) Аминопиридиновые производные в качестве ингибиторов ctps1
CY1125004T1 (el) Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας
EA201891278A1 (ru) Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа
EA201892246A1 (ru) Производные аминотиазола, полученные в качестве противовирусных средств
EA201692189A1 (ru) Соединения фосфина золота (i) в качестве антибактериальных агентов
EA201591328A1 (ru) Замещенные гетероциклом тетрациклические соединения и способы их применения для лечения вирусных заболеваний
EA201790234A1 (ru) 2'-хлораминопиримидиноновые и пиримидиндионовые нуклеозиды
EA202190854A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
UY36257A (es) “compuestos de imidazopiridazina”.
BR112016002638A2 (pt) novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório
EA201692190A1 (ru) Соединения фосфина золота (i) в качестве антибактериальных агентов
EA202190055A1 (ru) Производные пиразола в качестве ингибиторов malt1
EA201890421A1 (ru) Циклические соединения, пригодные в качестве модуляторов tnf-альфа